ArticleIEEE journal of translational engineering in health and medicine2026
mCardiacDx: Radar-Driven Contactless Monitoring and Diagnosis of Atrial Fibrillation.
Article in IEEE journal of translational engineering in health and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Contactless Cardiac Health Monitoring with Millimeter-Wave Radar Based on PMG-SATNet.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arrhythmia is a common cardiac condition that can precipitate severe complications without timely intervention. Among them, atrial fibrillation (AF) is the most common form. While continuous monitoring is essential for timely diagnosis, conventional approaches such as electrocardiogram (ECG) and wearable devices are constrained by their reliance on specialized medical expertise and patient discomfort from their contact nature. Existing contactless monitoring, primarily designed for healthy subjects, face significant challenges when analyzing reflections from AF patients due to disrupted spatial stability and temporal consistency caused by underlying irregular heart contractions. In this paper, we introduce mCardiacDx, a radar-driven contactless system that accurately analyzes these complex reflections and reconstructs heart pulse waveforms (HPWs) for AF monitoring and diagnosis. The key technical contributions of our work include a novel precise target localization (PTL) technique that accurately locates heart reflections despite spatial disruptions, an encoder-decoder model (HPR-Net) that effectively transforms these reflections into HPWs, addressing temporal inconsistencies, and a final analysis module for AF monitoring and diagnosis. Our evaluation on a dataset of 48 subjects (24 healthy, 24 with AF) in a seated, normal breathing, real-world setting shows that both mCardiacDx and the PTL technique significantly outperform the state-of-the-art approach in monitoring and diagnosing AF.
objectiveTo develop a contactless radar-driven system, mCardiacDx, that overcomes reflection disruption challenges in AF patients to accurately reconstruct interpretable heart pulse waveforms (HPWs) for monitoring and diagnosis. METHODS AND PROCEDURES: We introduce a PTL technique to locate heart reflections despite spatial disruptions, and an encoder-decoder model (HPR-Net) to robustly process reflections and reconstruct interpretable HPWs, addressing temporal inconsistencies. The HPWs are then processed by a final analysis module for AF monitoring and diagnosis. mCardiacDx is validated against a state-of-the-art approach (baseline) on a dataset of 48 subjects (24 healthy, 24 with AF) in a seated, normal breathing, real-world setting. This validation confirms the system's robustness and generalizability to real-world seated scenarios variations in posture and environment.
resultsmCardiacDx significantly outperforms the baseline in both monitoring and diagnosis. HPW fidelity (Dynamic time warping (DTW) score) for AF patients improves from 5.92 to 2.92. HR/RR interval median absolute percentage error (MedAPE) reduced (e.g., HR from 9.10 % to 2.94 %; RR interval from 8.42 % to 2.95 %). Our system achieves superior diagnostic performance with 0.93 accuracy, and 0.91 recall (sensitivity), significantly surpassing the baseline's accuracy of 0.85 and recall of 0.75, while both maintain a specificity of 0.96.
conclusionmCardiacDx is a robust, non-contact system for continuous cardiac care, addressing a critical gap in real-world AF monitoring and diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.